A variety of tumor associated antigens (TAA) expressed on pancreatic cancer cells have been targeted in various clinical trials to redirect CAR T cells against pancreatic cancer including MSLN, CEA, PSCA, MUC1, and HER2 (Table 1). Here, ERBB2 is linked to familial pancreatic carcinoma.